Find your next paid study

Imperative Care, Inc.NCT07491952

~$10 – $1,050

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes

This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less tha…

Diabetes Mellitus, Type 2

Eli Lilly and CompanyNCT07668336

~$50 – $2,250

Actual pay is set by the research site.

Systemic Lupus ErythematosusRheumatoid Arthritis

A Phase 1, First-in-Human, Single Ascending Dose, Open-label, Non-randomized Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of ABBV-519 in Subjects With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inf…

~$150 – $4,500

Actual pay is set by the research site.

AbbVieNCT07607964

Non-Nutritive SweetenerType 1 Diabetestype1diabetes+1 more

The Cardiometabolic Impact of Non-Nutritive Sweeteners in Young Adults With Type 1 Diabetes

This project will apply a novel non-nutritive sweetener (NNS) dietary assessment tool with measurement of circulating NNS levels in a pediatric population, all…

Medical College of WisconsinNCT07434544

~$10 – $750

Actual pay is set by the research site.

A Method of Dosing Vitamin D by Weight

Vitamin D is essential for calcium absorption and bone growth, brain development, and immune system function. Vitamin D is produced by the body in response to …

Hypovitaminosis D

Atlantic Health SystemNCT07876843

~$10 – $750

Actual pay is set by the research site.

A Phase 1/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

This study is to evaluate the safety, tolerability, PK, and preliminary efficacy of NTS071 in adults with TP53 Y220C-mutated solid tumors.

Advanced Solid Tumors

Nutshell Therapeutics (Shanghai) Co., LTD.NCT07060989

~$150 – $4,200

Actual pay is set by the research site.

Advanced/Metastatic Solid TumorsColorectal CancerGastric Cancer+5 more

Phase 1/2 Dose Escalation and Cohort Expansion Study Evaluating MCLA-158 (Petosemtamab) as Single Agent or in Combination in Advanced Solid Tumors

This is a Phase 1/2 open-label, multi-center, multi-national study with an initial dose escalation part to determine the recommended Phase II dose (RP2D) of MC…

~$150 – $4,500

Actual pay is set by the research site.

Merus B.V.NCT03526835

A Pilot Study Assessing the Safety and Efficacy of Histotripsy as an Adjunctive Treatment for Biliary Tract Cancer

The purpose of this pilot study is to examine the safety and feasibility of histotripsy in two cohorts of 12 patients each with Biliary Track Cancer (BTC), wit…

Biliary Track Cancer

NYU Langone HealthNCT07853690

~$10 – $1,125

Actual pay is set by the research site.

Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)

A Phase 1/1b Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 436 as Monotherapy and in Combination With Other Therapies in Participants With Microsatellite Instability-high (MSI-H)/Mismatch Repair Deficient (dMMR) Solid Tumors

The primary objectives of this trial are to evaluate the safety profile of AMG 436 and to determine the maximum tolerated dose (MTD) and/or the recommended dos…

Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament RupturePain+1 more

~$150 – $4,500

Actual pay is set by the research site.

AmgenNCT07403721

Phase 3

Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial (SM25091)

The goal of this clinical trial is to learn whether taking oral tranexamic acid (TXA) for one week after anterior cruciate ligament (ACL) reconstruction improv…

~$50 – $2,250

Actual pay is set by the research site.

Dave BernholtNCT07880743

GROWTH AND TOLERANCE OF A NEW INFANT FORMULA USING AN EXTENSIVELY HYDROLYZED CASEIN-BASED PROTEIN (eHCF)

This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one tha…

Growth

Mead Johnson NutritionNCT07513506

~$10 – $1,125

Actual pay is set by the research site.

Screening Evaluation of Volunteers for Studies of Pain

This study is a screening evaluation for volunteers who are interested in participating in National Center for Complementary and Integrative Health (NCCIH) res…

Pain